Kasen Pharma Products Private Limited
Founded in 2018 and headquartered in Tamil Nadu, India.
2018 | Chennai, Tamil Nadu (India) | Active
Kasen Pharma Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 216.03%
- Profit Growth 14.79%
- Ebitda 17.49%
- Net Worth -253.83%
- Total Assets 135.11%
About Kasen Pharma Products
Kasen Pharma Products Private Limited (KPPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 September 2018 (Six years and five months 9 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Balachandran and Sundar Sampath serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U36999TN2018PTC124797
- Company No.
124797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Manufacturing
Other Industry
Who are the key members and board of directors at Kasen Pharma Products?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balachandran  | Additional Director | 05-Aug-2021 | Current |
| Sundar Sampath | Additional Director | 05-Aug-2021 | Current |
Financial Performance of Kasen Pharma Products.
Kasen Pharma Products Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 216.03% increase. The company also saw a substantial improvement in profitability, with a 14.79% increase in profit. The company's net worth observed a substantial decline by a decrease of 253.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kasen Pharma Products?
Unlock access to Kasen Pharma Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Sathgruha Green Housing Private Limited
Sundar Sampath is a mutual person
- Soezy Solutions Private Limited
Sundar Sampath is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kasen Pharma Products?
Unlock and access historical data on people associated with Kasen Pharma Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kasen Pharma Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kasen Pharma Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
